Invention Grant
- Patent Title: Crystalline forms of thienopyrimidine derivative
-
Application No.: US16034002Application Date: 2018-07-12
-
Publication No.: US10464945B2Publication Date: 2019-11-05
- Inventor: Kazuhiro Miwa
- Applicant: Takeda Pharmaceutical Company Limited
- Applicant Address: JP Osaka
- Assignee: Takeda Pharmaceutical Company Limited
- Current Assignee: Takeda Pharmaceutical Company Limited
- Current Assignee Address: JP Osaka
- Agency: Cooley LLP
- Priority: JP2012-217679 20120928
- Main IPC: C07D495/04
- IPC: C07D495/04 ; C07D333/38 ; C07D409/12

Abstract:
The present invention provides a production method of a thienopyrimidine derivative or a salt thereof which has a gonadotropin releasing hormone (GnRH) antagonistic action with high quality in high yield. The present invention provides a method of producing a thienopyrimidine derivative, which comprises reacting 6-(4-aminophenyl)-1-(2,6-difluorobenzyl) -5-dimethylaminomethyl-3-(6-methoxypyridazin-3-yl)thieno[2,3-d]pyrimidine -2,4(1H,3H)-dione or salt thereof, 1,1′-carbonyldiimidazole or a salt thereof and methoxyamine or a salt thereof, and the like.
Public/Granted literature
- US20180319816A1 PRODUCTION METHOD OF THIENOPYRIMIDINE DERIVATIVE Public/Granted day:2018-11-08
Information query